{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T19:17:38Z","timestamp":1719861458281},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,8,1]]},"DOI":"10.2169\/internalmedicine.0855-22","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:10:25Z","timestamp":1670364625000},"page":"2249-2252","source":"Crossref","is-referenced-by-count":2,"title":["Methotrexate-induced Subacute Encephalopathy That Showed No Abnormalities on Magnetic Resonance Imaging Soon after Symptom Appearance"],"prefix":"10.2169","volume":"62","author":[{"given":"Haruna","family":"Fujisawa","sequence":"first","affiliation":[{"name":"Division of Hematology, Mitsui Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurika","family":"Mitsui","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mitsui Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Narukawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mitsui Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Shirasugi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mitsui Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Komaki","sequence":"additional","affiliation":[{"name":"Division of Neurology, Mitsui Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Hao","sequence":"additional","affiliation":[{"name":"Division of Neurology, Mitsui Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Neurology, Mitsui Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mitsui Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Khera S, Shijith KP, Goswami JN. Methotrexate encephalopathy presenting as choreoathetosis. BMJ Case Rep 14: e241509, 2021.","DOI":"10.1136\/bcr-2020-241509"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Linnebank M, Malessa S, Moskau S, et al. Acute methotrexate-induced encephalopathy - causal relation to homozygous allelic state for MTR c.2756A>G (D919G) ? J Chemother 19: 455-457, 2007.","DOI":"10.1179\/joc.2007.19.4.455"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Salkade PR, Lim TA. Methotrexate-induced acute toxic leukoencephalopathy. J Cancer Res Ther 8: 292-296, 2012.","DOI":"10.4103\/0973-1482.98993"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Watanabe K, Arakawa Y, Oguma E, et al. Characteristics of methotrexate-induced stroke-like neurotoxicity. Int J Hematol 108: 630-636, 2018.","DOI":"10.1007\/s12185-018-2525-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bhojwani D, Sabin ND, Pei D, et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 32: 949-959, 2014.","DOI":"10.1200\/JCO.2013.53.0808"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Rubnitz JE, Relling MV, Harrison PL, et al. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia. Leukemia 12: 1176-1181, 1998.","DOI":"10.1038\/sj.leu.2401098"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 19: 178-184, 2008.","DOI":"10.1093\/annonc\/mdm466"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ayalon I, Friedman S, Binenbaum Y, et al. A case of methotrexate neurotoxicity presented as status epilepticus, encephalopathy, and high fever. J Investig Med High Impact Case Rep 7: 2324709619862311, 2019.","DOI":"10.1177\/2324709619862311"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lee ACW, Li CH, Wong YC. Transient encephalopathy following high-dose methotrexate. Med Pediatr Oncol 41: 101, 2003.","DOI":"10.1002\/mpo.1339"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gonz\u00e1lez-Su\u00e1rez I, Aguilar-Amat MJ, Trigueros M, Borobia AM, Cruz A, Arpa J. Leukoencephalopathy due to oral methotrexate. Cerebellum 13: 178-183, 2014.","DOI":"10.1007\/s12311-013-0528-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Iwatani K, Fujii N, Deguchi S, Tanimoto M. Subacute methotrexate-related leukoencephalopathy with stroke-like presentation. Int J Hematol 96: 683-684, 2012.","DOI":"10.1007\/s12185-012-1194-7"},{"key":"12","unstructured":"12. Fisher MJ, Khademian ZP, Simon EM, Zimmerman RA, Bilaniuk LT. Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children. AJNR Am J Neuroradiol 26: 1686-1689, 2005."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hayakawa F, Sakura T, Yujiri T, et al. Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group. Blood Cancer J 4: e252, 2014.","DOI":"10.1038\/bcj.2014.72"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Teshima K, Kume M, Kondo R, et al. Methotrexate-induced transient encephalopathy in an adolescent and young adult patient with acute lymphoblastic leukemia. Intern Med 60: 2115-2118, 2021.","DOI":"10.2169\/internalmedicine.5937-20"},{"key":"15","unstructured":"15. Rollins N, Winick N, Bash R, Booth T. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR Am J Neuroradiol 25: 1688-1695, 2004."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamanaka K, Okata T, Sambongi Y, et al. Subacute methotrexate encephalopathy mimicking ischemic stroke with dynamic changes on magnetic resonance imaging. J Stroke Cerebrovasc Dis 27: e233-e235, 2018.","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.007"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/15\/62_0855-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T03:23:12Z","timestamp":1691205792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/15\/62_0855-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":16,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0855-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"article-number":"0855-22"}}